Cargando…
Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides
Many cationic antimicrobial peptides (AMPs) target the unique lipid composition of the prokaryotic cell membrane. However, the micromolar activities common for these peptides are considered weak in comparison to nisin, which follows a targeted, pore-forming mode of action. Here we show that AMPs can...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387250/ https://www.ncbi.nlm.nih.gov/pubmed/22768121 http://dx.doi.org/10.1371/journal.pone.0039768 |
_version_ | 1782237084641132544 |
---|---|
author | Arnusch, Christopher J. Pieters, Roland J. Breukink, Eefjan |
author_facet | Arnusch, Christopher J. Pieters, Roland J. Breukink, Eefjan |
author_sort | Arnusch, Christopher J. |
collection | PubMed |
description | Many cationic antimicrobial peptides (AMPs) target the unique lipid composition of the prokaryotic cell membrane. However, the micromolar activities common for these peptides are considered weak in comparison to nisin, which follows a targeted, pore-forming mode of action. Here we show that AMPs can be modified with a high-affinity targeting module, which enables membrane permeabilization at low concentration. Magainin 2 and a truncated peptide analog were conjugated to vancomycin using click chemistry, and could be directed towards specific membrane embedded receptors both in model membrane systems and whole cells. Compared with untargeted vesicles, a gain in permeabilization efficacy of two orders of magnitude was reached with large unilamellar vesicles that included lipid II, the target of vancomycin. The truncated vancomycin-peptide conjugate showed an increased activity against vancomycin resistant Enterococci, whereas the full-length conjugate was more active against a targeted eukaryotic cell model: lipid II containing erythrocytes. This study highlights that AMPs can be made more selective and more potent against biological membranes that contain structures that can be targeted. |
format | Online Article Text |
id | pubmed-3387250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-33872502012-07-05 Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides Arnusch, Christopher J. Pieters, Roland J. Breukink, Eefjan PLoS One Research Article Many cationic antimicrobial peptides (AMPs) target the unique lipid composition of the prokaryotic cell membrane. However, the micromolar activities common for these peptides are considered weak in comparison to nisin, which follows a targeted, pore-forming mode of action. Here we show that AMPs can be modified with a high-affinity targeting module, which enables membrane permeabilization at low concentration. Magainin 2 and a truncated peptide analog were conjugated to vancomycin using click chemistry, and could be directed towards specific membrane embedded receptors both in model membrane systems and whole cells. Compared with untargeted vesicles, a gain in permeabilization efficacy of two orders of magnitude was reached with large unilamellar vesicles that included lipid II, the target of vancomycin. The truncated vancomycin-peptide conjugate showed an increased activity against vancomycin resistant Enterococci, whereas the full-length conjugate was more active against a targeted eukaryotic cell model: lipid II containing erythrocytes. This study highlights that AMPs can be made more selective and more potent against biological membranes that contain structures that can be targeted. Public Library of Science 2012-06-29 /pmc/articles/PMC3387250/ /pubmed/22768121 http://dx.doi.org/10.1371/journal.pone.0039768 Text en Arnusch et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Arnusch, Christopher J. Pieters, Roland J. Breukink, Eefjan Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides |
title | Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides |
title_full | Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides |
title_fullStr | Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides |
title_full_unstemmed | Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides |
title_short | Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides |
title_sort | enhanced membrane pore formation through high-affinity targeted antimicrobial peptides |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387250/ https://www.ncbi.nlm.nih.gov/pubmed/22768121 http://dx.doi.org/10.1371/journal.pone.0039768 |
work_keys_str_mv | AT arnuschchristopherj enhancedmembraneporeformationthroughhighaffinitytargetedantimicrobialpeptides AT pietersrolandj enhancedmembraneporeformationthroughhighaffinitytargetedantimicrobialpeptides AT breukinkeefjan enhancedmembraneporeformationthroughhighaffinitytargetedantimicrobialpeptides |